Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Testa

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Antibiotics|November 1, 1970
Antibiotic 6640. II. Fermentation, isolation, and propertiesG H Wagman, R T Testa, J A Marquez
Annali Italiani Di Chirurgia|July 1, 1995
[TNM staging system of lung carcinoma: historical notes, limitations and controversies]G Motta, M A Nahum, T Testa, et al.
Psychopharmacology Bulletin|October 1, 1976
Experimental analysis of narcotic use in humansC P O'Brien, R Greenstein, T Testa, et al.
Psychopharmacology Bulletin|October 1, 1982
Rapid acquisition of conditioned responses to hydromorphone in detoxified heroin addictsJ W Ternes, C P O'Brien, T T Testa
The Journal of Antimicrobial Chemotherapy|April 1, 1995
Glycylcyclines: a new generation of tetracyclinesF T Tally, G A Ellestad, R T Testa
Tumori|April 25, 2000
Carcinosarcoma of the lung: a case reportT Testa, M Nahum, P Ceppa, et al.
The Pavlovian Journal of Biological Science|October 1, 1976
Conditioning in human opiate addictsC P O'Brien, T Testa, T J O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesW J Weiss, N V Jacobus, P J Petersen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability propertiesY Yang, R T Testa, N Bhachech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactamN V Jacobus, F W Immermann, J M Gupte, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Antibiotics|November 1, 1970
Antibiotic 6640. II. Fermentation, isolation, and propertiesG H Wagman, R T Testa, J A Marquez
Annali Italiani Di Chirurgia|July 1, 1995
[TNM staging system of lung carcinoma: historical notes, limitations and controversies]G Motta, M A Nahum, T Testa, et al.
Psychopharmacology Bulletin|October 1, 1976
Experimental analysis of narcotic use in humansC P O'Brien, R Greenstein, T Testa, et al.
Psychopharmacology Bulletin|October 1, 1982
Rapid acquisition of conditioned responses to hydromorphone in detoxified heroin addictsJ W Ternes, C P O'Brien, T T Testa
The Journal of Antimicrobial Chemotherapy|April 1, 1995
Glycylcyclines: a new generation of tetracyclinesF T Tally, G A Ellestad, R T Testa
Tumori|April 25, 2000
Carcinosarcoma of the lung: a case reportT Testa, M Nahum, P Ceppa, et al.
The Pavlovian Journal of Biological Science|October 1, 1976
Conditioning in human opiate addictsC P O'Brien, T Testa, T J O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1995
Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclinesW J Weiss, N V Jacobus, P J Petersen, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability propertiesY Yang, R T Testa, N Bhachech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactamN V Jacobus, F W Immermann, J M Gupte, et al.
Pageof 10